The REDDSTAR (Repair of Diabetic Damage by Stromal Cell Administration) consortium is a multinational collaboration involving academic groups in the EU with expertise in the vascular damage resulting from complications of diabetes mellitus. The aim of the REDDSTAR consortium is to significantly impact the management and treatment of the complications of diabetes mellitus. The collaboration is relevant to clinicians, researchers in diabetes mellitus, drug/ pharmaceutical companies and ultimately the general public. Our goal is to improve the treatments available for patients with microvascular damage and complications from diabetes, and to enhance their health and quality of life. Ultimately such improvements will lead to a reduction in public health costs associated with diabetes mellitus and related complications.
Please look below at our Industry Brochure.